Pathological forms of TDP-43 in amyotrophic lateral sclerosis (ALS) promote aberrant telomere elongation
- PMID: 40379219
- DOI: 10.1016/j.bbadis.2025.167906
Pathological forms of TDP-43 in amyotrophic lateral sclerosis (ALS) promote aberrant telomere elongation
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting motor neurons. TAR DNA-binding protein 43 (TDP-43) mis-localisation from the nucleus to the cytoplasm is the major pathological characteristic of ALS. Telomeres are repetitive DNA sequences found in complex with proteins at chromosomal ends. The shelterin protein complex protects telomeres from DNA damage by producing characteristic t-loop structures, and telomere repeat binding factor 2 (TRF2) has an essential role in this process. Telomere dysregulation is reported in ALS, but conflicting findings have been obtained. Here we examined if telomere dysregulation is present in cortical neurons in a mouse model with pathological mis-localisation of TDP-43 to the cytoplasm - TDP-43 rNLS - compared to controls, and in cortical primary neurons expressing TDP-43 ALS associated mutations (A315T, A90V). We demonstrate that telomeres are significantly longer and of more variable in length in the TDP-43 rNLS model compared to controls. This was proceeded by downregulation of TRF2 in early disease stages with subsequent upregulation of TRF2 at advanced disease in TDP-43 rNLS mice. Longer telomeres were also present in primary cortical neurons expressing mutant TDP-43. A trend towards TRF2 upregulation was also present in human ALS spinal cord lysates. We detected dysregulation of catalytic subunit of telomerase, TERT, and a trend towards upregulation of telomere interacting protein, Rif 1 in these mice and human ALS spinal cord lysates. The longer telomeres were independent of the alternative lengthening of telomeres (ALT) mechanism of maintaining telomere length. Similarly, no DNA damage at telomere sites was detected. Our findings imply that telomere protection is compromised in ALS, leading to longer telomeres in neurons in ALS associated with TDP-43 pathology.
Keywords: ALS; DNA damage; Neurodegeneration; TDP-43 pathology; Telomere dysfunction; Telomeres.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model.Acta Neuropathol Commun. 2025 May 24;13(1):116. doi: 10.1186/s40478-025-02005-z. Acta Neuropathol Commun. 2025. PMID: 40413526 Free PMC article.
-
CK1δ/ε-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis.Acta Neuropathol Commun. 2024 Dec 4;12(1):187. doi: 10.1186/s40478-024-01902-z. Acta Neuropathol Commun. 2024. PMID: 39633494 Free PMC article.
-
TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis.Acta Neuropathol Commun. 2025 Feb 24;13(1):42. doi: 10.1186/s40478-025-01934-z. Acta Neuropathol Commun. 2025. PMID: 39994742 Free PMC article.
-
Comparison of Telomere Structure in Eukaryotes.Arch Razi Inst. 2024 Dec 31;79(6):1365-1374. doi: 10.32592/ARI.2024.79.6.1365. eCollection 2024 Dec. Arch Razi Inst. 2024. PMID: 40606259 Free PMC article. Review.
-
Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2017 Jan 9;1(1):CD006049. doi: 10.1002/14651858.CD006049.pub2. Cochrane Database Syst Rev. 2017. PMID: 28067943 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous